The NDoH is now recommending dexamethasone (or equivalent) for patients with severe COVID-19 disease requiring respiratory support in the form of ventilation or supplemental oxygen.

Please see the attached circular for the full details. Please note that dexamethasone is not recommended for patients with mild disease.